Jan 13, 2022 / NTS GMT
Jong-Yoon Chun - Seegene, Inc. - Founder & CEO
Hello. This is Jong-Yoon Chun, the CEO and Founder of Seegene. Today, I will introduce Seegene's solutions for living with the COVID-19 and also the future of Seegene, which will be the opening of molecular diagnostics platform.
I will start with a brief overview of Seegene. Seegene was established in 2000 with the mission of global adoption of molecular diagnostics to daily life. Last year, our revenue was at about $1 billion and the profit was at $0.6 billion. Our global network has eight subsidiaries and about 100 distributors.
Seegene Medical Foundation is an affiliate company of Seegene and provide clinical testing services. As a molecular diagnostic company, we have to provide the solutions for living with COVID-19. 2021 was all about fight against the COVID-19 variants, but this year, we will have another fight to go back to normal.
In this graph, you can see COVID-19 is continuously mutating and causing multiple waves of pandemic. The first is outbreak; second, variations; third, Delta; and the fourth will
Seegene Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Mar 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers